Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Quinn

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Cancer Treatment Reviews|December 2, 2015
Low dose cyclophosphamide: Mechanisms of T cell modulationMutsa Tatenda Madondo, Michael Quinn, Magdalena Plebanski
Clinical & Experimental Metastasis|November 12, 2005
Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironmentNuzhat Ahmed, Clyde Riley, Greg Rice, et al.
Journal of Health Psychology|March 16, 2023
A validation of the body compassion scale in femalesLeesa M Van Niekerk, Gemma Muscella, Michael Quinn
Psycho-Oncology|June 9, 2005
Complementary medicine use by Australian women with gynaecological cancerMilica Markovic, Lenore Manderson, Natalie Wray, et al.
Frontiers in Immunology|October 4, 2016
CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive TherapiesCorinne J Smith, Michael Quinn, Christopher M Snyder
Journal of Cellular Biochemistry|August 14, 2012
Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistanceNuzhat Ahmed, Khalid Abubaker, Jock Findlay, et al.
Immunotherapy|January 21, 2016
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vectorMichael Quinn, Dan A Erkes, Christopher M Snyder
The Australasian Journal of Dermatology|November 18, 2003
Alopecia neoplastica caused by desmoplastic melanomaKerry Crotty, William McCarthy, Michael Quinn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 12, 2017
Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomyChloe Ayres, Gayanie Ratnayake, Orla McNally, et al.
Current Cancer Drug Targets|April 8, 2010
Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancerNuzhat Ahmed, Khalid Abubaker, Jock Findlay, et al.
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Cancer Treatment Reviews|December 2, 2015
Low dose cyclophosphamide: Mechanisms of T cell modulationMutsa Tatenda Madondo, Michael Quinn, Magdalena Plebanski
Clinical & Experimental Metastasis|November 12, 2005
Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironmentNuzhat Ahmed, Clyde Riley, Greg Rice, et al.
Journal of Health Psychology|March 16, 2023
A validation of the body compassion scale in femalesLeesa M Van Niekerk, Gemma Muscella, Michael Quinn
Psycho-Oncology|June 9, 2005
Complementary medicine use by Australian women with gynaecological cancerMilica Markovic, Lenore Manderson, Natalie Wray, et al.
Frontiers in Immunology|October 4, 2016
CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive TherapiesCorinne J Smith, Michael Quinn, Christopher M Snyder
Journal of Cellular Biochemistry|August 14, 2012
Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistanceNuzhat Ahmed, Khalid Abubaker, Jock Findlay, et al.
Immunotherapy|January 21, 2016
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vectorMichael Quinn, Dan A Erkes, Christopher M Snyder
The Australasian Journal of Dermatology|November 18, 2003
Alopecia neoplastica caused by desmoplastic melanomaKerry Crotty, William McCarthy, Michael Quinn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 12, 2017
Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomyChloe Ayres, Gayanie Ratnayake, Orla McNally, et al.
Current Cancer Drug Targets|April 8, 2010
Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancerNuzhat Ahmed, Khalid Abubaker, Jock Findlay, et al.
Pageof 17